A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

NCT03569553 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Inhalational Anthrax

Interventions

DRUG: AIGIV

Sponsor

Emergent BioSolutions

Collaborators

[object Object]
[object Object]